Literature DB >> 33915866

Pyrethroid Resistance Aggravation in Ugandan Malaria Vectors Is Reducing Bednet Efficacy.

Magellan Tchouakui1, Leon M J Mugenzi1,2, Benjamin D Menze1, Jude N T Khaukha3, Williams Tchapga1, Micareme Tchoupo1, Murielle J Wondji1,4, Charles S Wondji1,4.   

Abstract

Monitoring cases of insecticide resistance aggravation and the effect on the efficacy of control tools is crucial for successful malaria control. In this study, the resistance intensity of major malaria vectors from Uganda was characterised and its impact on the performance of various insecticide-treated nets elucidated. High intensity of resistance to the discriminating concentration (DC), 5× DC, and 10× DC of pyrethroids was observed in both Anopheles funestus and Anopheles gambiae in Mayuge and Busia leading to significant reduced performance of long-lasting insecticidal nets (LLINs) including the piperonyl butoxide (PBO)-based nets (Olyset Plus). Molecular analysis revealed significant over-expression of cytochrome P450 genes (CYP9K1 and CYP6P9a/b). However, the expression of these genes was not associated with resistance escalation as no difference was observed in the level of expression in mosquitoes resistant to 5× DC and 10× DC compared to 1× DC suggesting that other resistance mechanisms are involved. Such high intensity of pyrethroid resistance in Uganda could have terrible consequences on the effectiveness of insecticide-based interventions and urgent action should be taken to prevent the spread of super-resistance in malaria vectors.

Entities:  

Keywords:  An. funestus; CYP9K1; Uganda; cytochrome P450; malaria; metabolic resistance; resistance escalation; vector control

Year:  2021        PMID: 33915866     DOI: 10.3390/pathogens10040415

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  6 in total

1.  Resistance intensity status of Anopheles gambiae s.l. species at KOLOKOPE, eastern plateau Togo: A potential site to assess new vector control tools.

Authors:  Koffi Mensah Ahadji-Dabla; Joseph Chabi; Yawo Georges Apetogbo; Edoh Koffi; Melinda Patricia Hadi; Guillaume Koffivi Ketoh
Journal:  Heliyon       Date:  2022-06-22

2.  Use of novel lab assays to examine the effect of pyrethroid-treated bed nets on blood-feeding success and longevity of highly insecticide-resistant Anopheles gambiae s.l. mosquitoes.

Authors:  Priscille Barreaux; Jacob C Koella; Raphael N'Guessan; Matthew B Thomas
Journal:  Parasit Vectors       Date:  2022-03-28       Impact factor: 3.876

3.  Fitness cost of target-site and metabolic resistance to pyrethroids drives restoration of susceptibility in a highly resistant Anopheles gambiae population from Uganda.

Authors:  Magellan Tchouakui; Ambrose Oruni; Tatiane Assatse; Claudine R Manyaka; Micareme Tchoupo; Jonathan Kayondo; Charles S Wondji
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

4.  Molecular Drivers of Multiple and Elevated Resistance to Insecticides in a Population of the Malaria Vector Anopheles gambiae in Agriculture Hotspot of West Cameroon.

Authors:  Arnaud Tepa; Jonas A Kengne-Ouafo; Valdi S Djova; Magellan Tchouakui; Leon M J Mugenzi; Rousseau Djouaka; Constant A Pieme; Charles S Wondji
Journal:  Genes (Basel)       Date:  2022-07-06       Impact factor: 4.141

5.  Marked aggravation of pyrethroid resistance in major malaria vectors in Malawi between 2014 and 2021 is partly linked with increased expression of P450 alleles.

Authors:  Benjamin D Menze; Magellan Tchouakui; Leon M J Mugenzi; Williams Tchapga; Micareme Tchoupo; Murielle J Wondji; Martin Chiumia; Themba Mzilahowa; Charles S Wondji
Journal:  BMC Infect Dis       Date:  2022-07-30       Impact factor: 3.667

Review 6.  The Antiplasmodial Potential of Medicinal Plants Used in the Cameroonian Pharmacopoeia: An Updated Systematic Review and Meta-Analysis.

Authors:  Arnaud Gabin N Tepa; Panthaleon Ambassa; Lawrence S Ayong; Prosper Cabral Biapa Nya; Constant Anatole Pieme
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-08       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.